|
KLRAQ1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.66699999973419E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.0863000044512E-08 |
| Normal-vs-Stage2 |
6.233400E-04 |
| Normal-vs-Stage3 |
2.775700E-04 |
| Normal-vs-Stage4 |
3.53110000128609E-08 |
| Stage1-vs-Stage2 |
3.710800E-01 |
| Stage1-vs-Stage3 |
4.500800E-01 |
| Stage1-vs-Stage4 |
3.988300E-02 |
| Stage2-vs-Stage3 |
8.260600E-01 |
| Stage2-vs-Stage4 |
2.895400E-03 |
| Stage3-vs-Stage4 |
9.736400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.90510000289635E-08 |
| Normal-vs-AfricanAmerican |
3.30309999996281E-06 |
| Normal-vs-Asian |
1.556000E-01 |
| Caucasian-vs-AfricanAmerican |
9.839400E-01 |
| Caucasian-vs-Asian |
2.887200E-01 |
| AfricanAmerican-vs-Asian |
4.030800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.1264999457199E-09 |
| Normal-vs-Female |
1.171920E-04 |
| Male-vs-Female |
1.566820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.41120000002526E-06 |
| Normal-vs-Extreme_Weight |
3.85550480430652E-11 |
| Normal-vs-Obese |
5.82729999999421E-05 |
| Normal-vs-Extreme_Obese |
6.839500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.625600E-01 |
| Normal_Weight-vs-Obese |
2.565600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.365800E-01 |
| Extreme_Weight-vs-Obese |
6.392300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.538400E-01 |
| Obese-vs-Extreme_Obese |
8.096600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.553800E-04 |
| Normal-vs-Age(41-60Yrs) |
5.75940000024922E-07 |
| Normal-vs-Age(61-80Yrs) |
1.8381999999928E-07 |
| Normal-vs-Age(81-100Yrs) |
5.449200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.521600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.400800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.911200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.367000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.992400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.720400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.18630000162301E-09 |
| Normal-VS-Type2 PRCC |
1.589490E-04 |
| Normal-VS-KIRP CIMP |
4.400500E-04 |
| Normal-VS-Unclassified PRCC |
4.583800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.582800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.707000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.415800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.308800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.609000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.813800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.12930003921031E-09 |
| Normal-vs-N1 |
2.30209999999564E-05 |
| Normal-vs-N2 |
1.991380E-04 |
| N0-vs-N1 |
3.048600E-01 |
| N0-vs-N2 |
2.201200E-01 |
| N1-vs-N2 |
9.396500E-02 |
|
|
